JP2024044791A - Culture medium for intestinal bacteria and culture method for intestinal bacteria - Google Patents
Culture medium for intestinal bacteria and culture method for intestinal bacteria Download PDFInfo
- Publication number
- JP2024044791A JP2024044791A JP2022150537A JP2022150537A JP2024044791A JP 2024044791 A JP2024044791 A JP 2024044791A JP 2022150537 A JP2022150537 A JP 2022150537A JP 2022150537 A JP2022150537 A JP 2022150537A JP 2024044791 A JP2024044791 A JP 2024044791A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- culture
- gam
- intestinal bacteria
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 101
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 80
- 239000001963 growth medium Substances 0.000 title claims abstract description 61
- 238000012136 culture method Methods 0.000 title abstract description 11
- 239000002609 medium Substances 0.000 claims abstract description 274
- 239000008280 blood Substances 0.000 claims abstract description 69
- 210000004369 blood Anatomy 0.000 claims abstract description 69
- 241000282414 Homo sapiens Species 0.000 claims abstract description 38
- 241000283073 Equus caballus Species 0.000 claims abstract description 31
- 238000012258 culturing Methods 0.000 claims abstract description 24
- 241001494479 Pecora Species 0.000 claims abstract description 16
- 241000894007 species Species 0.000 claims description 72
- 241000305071 Enterobacterales Species 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 11
- 241000282412 Homo Species 0.000 claims description 4
- 241000283086 Equidae Species 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 description 28
- 230000001580 bacterial effect Effects 0.000 description 26
- 210000000936 intestine Anatomy 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 9
- 241000193174 Butyrivibrio crossotus Species 0.000 description 8
- 241000862470 Holdemania filiformis Species 0.000 description 8
- 241000123753 Ruminococcus bromii Species 0.000 description 8
- 241001580973 Subdoligranulum variabile Species 0.000 description 8
- 241001531188 [Eubacterium] rectale Species 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 241000428313 Anaerotruncus colihominis Species 0.000 description 4
- 241000217846 Bacteroides caccae Species 0.000 description 4
- 241001135322 Bacteroides eggerthii Species 0.000 description 4
- 241000402140 Bacteroides finegoldii Species 0.000 description 4
- 241000606124 Bacteroides fragilis Species 0.000 description 4
- 241000047484 Bacteroides intestinalis Species 0.000 description 4
- 241001135228 Bacteroides ovatus Species 0.000 description 4
- 241000204294 Bacteroides stercoris Species 0.000 description 4
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 4
- 241000606219 Bacteroides uniformis Species 0.000 description 4
- 241000194002 Blautia hansenii Species 0.000 description 4
- 241000123777 Blautia obeum Species 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 241001262170 Collinsella aerofaciens Species 0.000 description 4
- 241000949098 Coprococcus comes Species 0.000 description 4
- 241001531200 Dorea formicigenerans Species 0.000 description 4
- 241000016537 Dorea longicatena Species 0.000 description 4
- 241001531192 Eubacterium ventriosum Species 0.000 description 4
- 241000606210 Parabacteroides distasonis Species 0.000 description 4
- 241000204306 Parabacteroides merdae Species 0.000 description 4
- 241001528479 Pseudoflavonifractor capillosus Species 0.000 description 4
- 241000398180 Roseburia intestinalis Species 0.000 description 4
- 241000202356 Ruminococcus lactaris Species 0.000 description 4
- 241001147795 Tyzzerella nexilis Species 0.000 description 4
- 241000342876 [Clostridium] asparagiforme Species 0.000 description 4
- 241001147801 [Clostridium] scindens Species 0.000 description 4
- 241001464867 [Ruminococcus] gnavus Species 0.000 description 4
- 241001464870 [Ruminococcus] torques Species 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 241000606125 Bacteroides Species 0.000 description 3
- 241001105998 Bacteroides dorei Species 0.000 description 3
- 241000543747 Parabacteroides johnsonii Species 0.000 description 3
- 244000005709 gut microbiome Species 0.000 description 3
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 2
- 241000115153 Bacteroides xylanisolvens Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241001657508 Eggerthella lenta Species 0.000 description 2
- 241000588921 Enterobacteriaceae Species 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000160321 Parabacteroides Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 241001300301 uncultured bacterium Species 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
この発明は、多種の腸内細菌の培養に共通して使用可能な培養技術に関し、特に前培養に用いる培地に工夫を加えることで、多種の腸内細菌を同時に培養可能とする培養技術に関する。 The present invention relates to a culture technique that can be commonly used for culturing a wide variety of enterobacteria, and particularly to a culture technique that makes it possible to simultaneously cultivate a variety of enterobacteria by modifying the medium used for preculture.
近年、腸内細菌がヒトの健康状態に大きな影響を与えることが明らかになり、その機能を解明するために糞便中の腸内細菌のDNAを直接解読する菌叢解析(培養を介さない解析)が盛んに行われている。しかし、菌叢解析によって得られるDNAの塩基配列の半分が機能未知であるため、菌叢によってすべての腸内細菌の機能を解明することは困難であり、腸内細菌を培養して直接その機能を研究・解明することが求められている。 In recent years, it has become clear that intestinal bacteria have a significant impact on human health, and in order to elucidate their functions, bacterial flora analysis (analysis without culture) is being actively conducted, in which the DNA of intestinal bacteria in feces is directly decoded. However, because the function of half of the DNA base sequences obtained from bacterial flora analysis is unknown, it is difficult to elucidate the functions of all intestinal bacteria using bacterial flora, and there is a demand to culture intestinal bacteria and directly study and elucidate their functions.
多くの腸内細菌について、等しい条件で表現型を比較するためには、一度に多種の細菌を培養できる培地が必要である。ところが、欧米人の腸内常在菌叢最優勢種56種(表1参照)のうち、現在までにヒトによる培養に成功し、菌株を保存・配布している機関から入手可能な45種、同様に、日本人の腸内常在菌叢最優勢種50種(表2参照)のうち入手可能な41種については、配布機関が種ごとに指定する培養液(表1、表2参照)が推奨されるという問題がある。 In order to compare the phenotypes of many intestinal bacteria under equal conditions, a medium capable of culturing many kinds of bacteria at once is necessary. However, of the 56 most dominant species of intestinal flora in Westerners (see Table 1), 45 species have been successfully cultured by humans to date and are available from institutions that preserve and distribute strains, and similarly, of the 50 most dominant species of intestinal flora in Japanese people (see Table 2), 41 species are available, but the problem is that the culture medium recommended for each species by the distribution institution (see Tables 1 and 2) is specified by the distribution institution.
つまり、マルチウェルプレート等で多種の腸内細菌を同時に培養する場合、菌ごとに異なる推奨培地を用いるとすると、ウェルごとに異なる培地を用意する必要があり、これに多大な時間、労力、費用がかかるという問題が生じる。また、ウェルごとに培地が異なると、沈殿物の有無などにより、各ウェルの培養液が不均一になり、すべてのウェルで同時に菌の増殖を測定し、比較することができなくなるという問題がある。 In other words, when culturing multiple types of enterobacteria simultaneously in a multi-well plate or the like, if a different recommended medium is used for each bacterium, it is necessary to prepare a different medium for each well, which creates the problem of taking a lot of time, effort, and cost. In addition, if the medium is different for each well, the culture medium in each well will become uneven due to the presence or absence of precipitate, etc., and there is a problem that it will be impossible to measure and compare the growth of bacteria in all wells at the same time.
そこで、本発明者らは、沈殿物を生成せず、かつ多数の腸内細菌種を培養できる培地の開発に着手し、前培養と本培養の両方を岐阜大学処方嫌気性培地(以下、「GAM培地」という。)で培養する方法で、欧米人腸内常在細菌叢最優勢56種のうち入手可能な45種を培養し、その32種について培養に成功している。(非特許文献1参照)。 The inventors therefore embarked on the development of a medium capable of culturing a large number of intestinal bacterial species without producing precipitates, and by culturing both pre-culture and main culture in Gifu University prescribed anaerobic medium (hereinafter referred to as "GAM medium"), they were able to culture 45 available species out of the 56 most dominant species of bacterial flora normally present in the intestines of Westerners, and were successful in culturing 32 of those species (see Non-Patent Document 1).
また、非特許文献2では、GAM培地に改良を加え、色が薄く透明度の高いmGAM培地を用いて欧米人腸内常在細菌叢最優勢45種を培養し、34種(76%)が増殖したことが報告されている。 In addition, Non-Patent Document 2 reports that an improved version of GAM medium, mGAM medium with a light color and high transparency, was used to culture the 45 most dominant species of bacterial flora commonly found in the intestines of Europeans and Americans, and 34 species (76%) proliferated.
また、化学的に定義されたGMMなる培地により、非特許文献3では、糞便サンプルから検出される属の70%が、非特許文献4では、その科の71%が分離培養可能であると報告されており、また、非特許文献2では、同培地により、欧米人腸内常在細菌叢最優勢45種のうち33種(73%)が培養可能であるという報告がなされている。 In addition, Non-Patent Document 3 reports that 70% of the genera detected in fecal samples can be isolated and cultured using a chemically defined medium called GMM, and Non-Patent Document 4 reports that 71% of the families can be isolated and cultured. Furthermore, Non-Patent Document 2 reports that 33 of the 45 most dominant species of bacterial flora commonly found in the intestines of Europeans and Americans (73%) can be cultured using the same medium.
しかし、非特許文献1、乃至非特許文献4で開示された培養方法では、未だ十分な種の腸内細菌を共通して培養することができないという問題がある。
本発明は、上記課題に鑑みてなされたものであり、腸内細菌のより多くの種を培養可能な培養培地、及び培養方法の提供を目的とする。
However, the culture methods disclosed in Non-Patent Documents 1 to 4 have a problem in that they are still unable to commonly culture a sufficient number of species of enterobacteria.
The present invention has been made in consideration of the above problems, and aims to provide a culture medium and a culture method capable of culturing a greater number of species of enterobacteria.
上記課題を解決するためになされた発明は、本培養培地を用いてヒトの腸内細菌の本培養を行う前の前培養に使用可能な腸内細菌前培養培地であって、GAM系培地に哺乳動物の血液を添加したことを特徴とする。 The invention made to solve the above problems is an intestinal bacteria preculture medium that can be used for preculture before main culture of human intestinal bacteria using a main culture medium, and which is a GAM-based medium. It is characterized by the addition of mammalian blood.
本発明の腸内細菌前培養培地は、このようにGAM系培地に哺乳動物の血液を添加したので、多くの種類の腸内細菌を同時に培養することができる。 The enterobacteria preculture medium of the present invention is a GAM-based medium to which mammalian blood has been added, making it possible to simultaneously culture many types of enterobacteria.
前記哺乳動物の血液は、ヒト、ウマ、及びヒツジからなる群より選ばれる少なくとも1種の哺乳動物の血液であることが好ましい。こうすることで、より多くの種の腸内細菌を培養できる。 The mammalian blood is preferably blood of at least one mammalian species selected from the group consisting of humans, horses, and sheep. This allows a greater variety of intestinal bacteria to be cultured.
前記哺乳動物の血液は、ウマの血液であることが好ましい。こうすることで、より一層多くの種の腸内細菌を培養できる。 Preferably, the mammalian blood is horse blood. In this way, even more species of intestinal bacteria can be cultured.
本発明は、GAM系培地とウマの血液を含むEG培地を混合することによりGAM系培地にウマの血液を添加してなるものでもよい。こうすることで、GAM系培地にウマの血液を添加した培地と同様に多くの種の腸内細菌を培養できる。 In the present invention, horse blood may be added to a GAM-based medium by mixing a GAM-based medium and an EG medium containing horse blood. By doing so, many species of intestinal bacteria can be cultured in the same manner as in a GAM-based medium to which horse blood is added.
前記哺乳動物の血液の体積濃度は、2.0%以上、6.0%(v/v)以下であることが好ましい。こうすることでさらに多くの種類の腸内細菌を培養できる。 The volume concentration of the mammal's blood is preferably 2.0% or more and 6.0% (v/v) or less. In this way, even more types of intestinal bacteria can be cultured.
本発明は、腸内細菌の前培養を行う前培養培地と、当該前培養培地で培養した腸内細菌の本培養を行う本培養培地とからなる腸内細菌培養組培地であって、GAM系培地に哺乳動物の血液を添加してなる前培養培地と、GAM系培地、EG培地から馬無菌脱繊血を除去したEGMB培地、又はGAM系培地とEGMB培地を混合した培地からなる本培養培地とを備える腸内細菌培養組培地を含む。 The present invention provides a culture medium for enteric bacteria, comprising a preculture medium for preculturing enterobacteria, and a main culture medium for main culturing enterobacteria cultured in the preculture medium, which is a GAM-based culture medium. A main culture medium consisting of a preculture medium obtained by adding mammalian blood to a medium, and a GAM-based medium, an EGMB medium obtained by removing horse sterile defibrinated blood from an EG medium, or a mixed medium of a GAM-based medium and an EGMB medium. and an enteric bacteria culture medium.
本発明は、哺乳動物の血液を添加したGAM系培地を用いて腸内細菌の前培養を行う前培養工程と、本培養培地を用いて前培養工程で培養した腸内細菌の培養を行う本培養工程とを備えることを特徴とする腸内細菌培養方法を含む。 The present invention includes a method for culturing intestinal bacteria, which is characterized by comprising a pre-culture step in which intestinal bacteria are pre-cultured using a GAM-based medium supplemented with mammalian blood, and a main culture step in which the intestinal bacteria cultured in the pre-culture step are cultured using a main culture medium.
本発明の腸内細菌培養方法は、前培養工程において、前培養時間の異なる腸内細菌を、本培養工程が開始する時刻からそれぞれの培養時間だけ前にマルチウェルに植菌するようにして、培養時間の長い腸内細菌から順に前記マルチウェルに植菌することが好ましい。
こうすることで、培養時間の異なる腸内細菌を培養する際に前培養時間を節約できる。
尚、ここで「マルチウェル」とは、1枚のプレートに多数のウェルを設けたマルチウェルプレートに限らず、バイアル瓶をマルチウェルプレート状に多数並べたものを含むものとする。
In the intestinal bacteria culture method of the present invention, in the pre-culture step, intestinal bacteria with different pre-culture times are preferably inoculated into the multi-well a respective culture time before the start of the main culture step, with the intestinal bacteria with the longest culture time being inoculated into the multi-well in ascending order.
This saves pre-incubation time when culturing enterobacteria that require different incubation times.
It should be noted that the term "multi-well" used herein is not limited to a multi-well plate having many wells on one plate, but includes a multi-well plate in which many vials are arranged.
また、これに続く本培養工程では、前培養工程で用いた前記マルチウェルから別のマルチウェルに菌を一斉に移植したのち、当該マルチウェルに移植された細菌を同じ培養時間で本培養することが好ましい。こうすることで、多数の腸内細菌をさらに効率よく培養できる。 In addition, in the main culture step that follows, after transplanting the bacteria from the multiwell used in the preculture step to another multiwell all at once, the bacteria transplanted to the multiwell are main cultured for the same culture time. is preferred. In this way, a large number of intestinal bacteria can be cultured more efficiently.
このように、本発明の腸内細菌前培養培地、腸内細菌培養組培地、及び腸内細菌培養方法によれば、多くの種の腸内細菌を同時に培養することができる。 Thus, according to the enterobacteria preculture medium, enterobacteria culture medium, and enterobacteria culture method of the present invention, many species of enterobacteria can be cultured simultaneously.
以下、本発明の一の実施形態について詳述する。ただし、本発明は、以下の実施形態に限られるものではない。 Hereinafter, one embodiment of the present invention will be described in detail. However, the present invention is not limited to the following embodiments.
(腸内細菌前培養培地)
本実施形態に係る腸内細菌前培養培地(以下、単に「前培養培地」ともいう。)は、ヒトの腸内細菌を培養する際の本培養に先がけて実施される前培養に用いるもので、GAM系培地に哺乳動物の血液を添加して形成される。
(Intestinal bacteria preculture medium)
The intestinal bacteria preculture medium (hereinafter also simply referred to as "preculture medium") according to the present embodiment is used for preculture performed prior to main culture when culturing human intestinal bacteria. , is formed by adding mammalian blood to a GAM-based medium.
(GAM系培地)
前培養培地の形成に用いるGAM系培地としては、GAMブイヨン、又は変法GAMブイヨンから形成したGAM液体培地の他、GAM寒天培地、変法GAM寒天培地、GAM半流動高層培地(いずれも日水製薬株式会社製を用いることができる。)を適宜に用いることができる。GAM系培地としては、GAMブイヨン、又は変法GAMブイヨンから形成したGAM液体培地がマルチウェルプレート上で操作しやすい点で好ましく、GAMブイヨンから形成したGAM液体培地が、多くの腸内細菌の培養を可能とする点で、特に好ましい。
(GAM-based medium)
As the GAM-based medium used for forming the preculture medium, in addition to GAM liquid medium formed from GAM bouillon or modified GAM bouillon, GAM agar medium, modified GAM agar medium, and GAM semi-fluid high-layer medium (all of which can be manufactured by Nissui Pharmaceutical Co., Ltd.) can be appropriately used. As the GAM-based medium, GAM liquid medium formed from GAM bouillon or modified GAM bouillon is preferred because it is easy to handle on a multi-well plate, and GAM liquid medium formed from GAM bouillon is particularly preferred because it allows the cultivation of many enterobacteria.
(混合培地)
GAM系培地に哺乳動物の血液を添加する方法として、哺乳類の血液を含む培地をGAM系培地に混合する方法がある。GAM系培地に混合することにより哺乳動物の血液を添加することとなる培地としては、EG培地、馬血液寒天培地(日水製薬株式会社製を用いることができる)、馬脱繊維血液添加Brucella agar平板培地(ベクトン・ディッキンソン アンド カンパニー社製を用いることができる)が挙げられ、EG培地が、ウマの血液を含みGAM系培地に対するウマの血液の添加を容易にする点で好ましく、かつGAM系培地と混合することで多種の腸内細菌を培養可能な点で好ましい。GAM系培地と、EG培地の体積混合比(GAM系培地/EG培地)は、0.5以上2.0以下が好ましく、0.9以上1.1以下が特に好ましい。以下、GAM培地とEG培地の混合培地をGE培地という。「GAM系培地」と「EG培地」の混合培地は、「GE系培地」と称するものとする。
(mixed medium)
As a method for adding mammalian blood to a GAM-based medium, there is a method of mixing a medium containing mammalian blood with a GAM-based medium. Examples of the culture medium to which mammalian blood is added by mixing with the GAM-based culture medium include EG medium, horse blood agar medium ( manufactured by Nissui Pharmaceutical Co., Ltd. ), and Brucella agar supplemented with horse defibrinated blood. A plate medium (made by Becton Dickinson & Company) can be mentioned, and EG medium is preferable because it contains horse blood and facilitates the addition of horse blood to GAM-based medium, and GAM-based medium This is preferable in that it is possible to culture a wide variety of intestinal bacteria by mixing with. The volume mixing ratio of the GAM-based medium and the EG medium (GAM-based medium/EG medium) is preferably 0.5 or more and 2.0 or less, particularly preferably 0.9 or more and 1.1 or less. Hereinafter, a mixed medium of GAM medium and EG medium will be referred to as GE medium. A mixed medium of "GAM-based medium" and "EG medium" shall be referred to as "GE-based medium."
(哺乳動物の血液)
GAM系培地に添加する哺乳動物の血液としては、特に限定されず、ヒト、ウマ、ヒツジ、ウシ、ウサギ、ヤギ、ロバ、イヌ、ネコ等公知の哺乳動物の血液を適宜に用いることができ、ヒト、ウマ、ヒツジが、多くのヒトの腸内常在細菌を培養できる点で好ましく、ウマの血液が、より多くの腸内常在細菌を培養できる点で、特に好ましい。以下、GAM培地にウマ血液を添加した培地をGB培地といい、ヒツジの血液を添加した培地をGB(sheep)培地といい、ヒトの血液を添加した培地をGB(human)培地という。
(mammalian blood)
The mammalian blood to be added to the GAM-based medium is not particularly limited, and known mammalian blood such as human, horse, sheep, cow, rabbit, goat, donkey, dog, cat, etc. can be used as appropriate. Humans, horses, and sheep are preferable because many human intestinal resident bacteria can be cultured, and horse blood is particularly preferable because more intestinal intestinal bacteria can be cultured. Hereinafter, a medium obtained by adding horse blood to a GAM medium is referred to as a GB medium, a medium added to a sheep blood is referred to as a GB (sheep) medium, and a medium to which human blood is added is referred to as a GB (human) medium.
(腸内細菌本培養培地(以下、単に「本培養培地」といいう。))
本培地用培地として用いる培地は、特に限定されないが、GAM系培地、EG培地から馬無菌脱繊血を除去したEGMB培地、又はGAM系培地とEGMB培地を混合した培地を用いることができ、GAM系培地、EG培地から馬無菌脱繊血を除去したEGMB培地、又はGAM系培地とEGMB培地を混合した培地が、より多種の腸内細菌を共通して培養できる点で好ましい。
また、作製が容易で、かつ透明度が高く吸光度(OD600)が測定しやすい点で、本培養にGAM液体培地を用いることが好ましい。
(Enterobacteria main culture medium (hereinafter simply referred to as "main culture medium"))
The medium used for this culture medium is not particularly limited, but may be a GAM-based medium, an EGMB medium obtained by removing sterile defibrated horse blood from EG medium, or a medium obtained by mixing a GAM-based medium and an EGMB medium. GAM-based medium, an EGMB medium obtained by removing sterile defibrated horse blood from EG medium, or a medium obtained by mixing a GAM-based medium and an EGMB medium are preferred in that they can commonly culture a wider variety of enterobacteria.
In addition, it is preferable to use GAM liquid medium for the main culture, since it is easy to prepare, has high transparency, and allows easy measurement of absorbance (OD 600 ).
(組培地)
組培地は、前培養培地と本培養培地とからなる。上述した前培養培地と本培養培地を適宜に組み合わせて組培地とすることができるが、前培養培地と本培養培地の組合せが、GE培地とGAM系培地、GB培地とGAM系培地、GE培地とEGMB培地、GE培地と(GAM系培地+EGMB培地)のいずれかの組合せが好ましく、GB培地とGAM系培地の組合せが特に好ましい。
(Combined medium)
The combination medium is composed of a pre-culture medium and a main culture medium. The above-mentioned pre-culture medium and main culture medium can be appropriately combined to form a combination medium, but the combination of the pre-culture medium and the main culture medium is preferably any combination of GE medium and GAM-based medium, GB medium and GAM-based medium, GE medium and EGMB medium, or GE medium and (GAM-based medium + EGMB medium), and the combination of GB medium and GAM-based medium is particularly preferable.
(腸内細菌培養方法)
本実施形態に係る腸内細菌培養方法は、前培養工程S1と、本培養工程S2とを備えている。本実施形態では、多種の腸内細菌について同時に培養を行う。
(Intestinal bacteria culture method)
The intestinal bacteria culture method according to this embodiment includes a preculture step S1 and a main culture step S2. In this embodiment, various types of intestinal bacteria are simultaneously cultured.
(前培養工程S1)
前培養工程S1は、腸内細菌を培養するにあたり、本培養工程S2に先がけて行われる培養工程である。前培養工程S1では、前培養培地として哺乳動物の血液を添加したGAM系培地が用いられる。
(Preculture step S1)
The pre-culture step S1 is a culture step that is carried out prior to the main culture step S2 when culturing enterobacteria. In the pre-culture step S1, a GAM-based medium to which mammalian blood has been added is used as the pre-culture medium.
前培養工程S1では、まず培養対象の腸内細菌を、これを保管したグリセロールストックから滅菌済みつまようじ等適宜の方法により、予め前培養培地が分注されたバイアル瓶やマルチウェルプレートに、嫌気状態で移植する。前培養培地は、前培養工程S1の開始前に作製され、嫌気状態に形成しておく。 In the preculture step S1, enterobacteriaceae to be cultured are first transferred from a stored glycerol stock into a vial or multiwell plate into which a preculture medium has been dispensed in advance using a sterilized toothpick or other suitable method under anaerobic conditions. Port it with. The preculture medium is prepared before the start of the preculture step S1 and is kept in an anaerobic state.
前培養時間は、腸内細菌の種類によって異なり、培養する腸内細菌は、例えば、24時間、48時間、又は96時間前培養するグループに分類され、96時間培養するものは、本培養開始96時間前に前培養を開始し、48時間前培養するもの、24時間培養するものは、それぞれ本培養を開始する48時間、24時間前に培養を開始する。各腸内細菌は、予め分譲機関が推奨する培地や前培養に用いる培地を、寒天培地にしたもの等の増殖が視認しやすい培地により培養を行い、一定時間ごとに増殖の度合いを目視で観察して、培養時間を決定する。培養時間は24時間ごとに限らず、適宜の時間ごとに分けることができ、3つのグループに限らず、2以下、又は4以上のグループに分けてもよい。 The pre-culture time varies depending on the type of enterobacteria. Enterobacteria to be cultured are classified into groups that are pre-cultured for, for example, 24 hours, 48 hours, or 96 hours. For those that are pre-cultured for 96 hours, pre-culture is started 96 hours before the start of main culture, and for those that are pre-cultured for 48 hours and for those that are pre-cultured for 24 hours, culture is started 48 hours and 24 hours before the start of main culture, respectively. Each enterobacteria is cultured in a medium that allows easy visual confirmation of growth, such as a medium recommended by the distributor or a medium used for pre-culture made into an agar medium, and the degree of growth is visually observed at regular intervals to determine the culture time. The culture time is not limited to 24 hours, but can be divided into appropriate intervals, and is not limited to three groups, but may be divided into two or less, or four or more groups.
ここで、培養時間の異なる腸内細菌を同じマルチウェルプレート上に順に移植することが好ましい。あるいは、バイアル瓶等で前培養した前培養時間の腸内細菌を、1枚のマルチウェルプレート上に分注してもよい。こうすることで、前培養時間の異なる腸内細菌を前培養後、コピープレートで一度に本培養用のマルチウェルプレートに移植できる。 Here, it is preferable to transplant the enterobacteria with different culture times onto the same multi-well plate in sequence. Alternatively, the enterobacteria with different pre-culture times pre-cultured in vials or the like may be dispensed onto one multi-well plate. In this way, after pre-culture, the enterobacteria with different pre-culture times can be transplanted onto the multi-well plate for main culture at the same time using a copy plate.
(本培養工程S2)
本培養工程S2は、前培養工程S1で培養した腸内細菌を、本培養培地で培養を行う工程である。予め嫌気条件で保管した培地をマルチウェルプレート等に分注し、これに、前培養工程S1で培養した腸内細菌を移植して培養を行う。
(Main culture step S2)
The main culture step S2 is a step of culturing the intestinal bacteria cultured in the preculture step S1 in a main culture medium. A medium stored in advance under anaerobic conditions is dispensed into a multiwell plate or the like, and the intestinal bacteria cultured in the preculture step S1 are transplanted thereto and cultured.
腸内細菌の生育度は、例えば、Multiskan(登録商標)GOマイクロプレートスペクトロフォトメータ(Thermo Fisher Scintific;製品番号51119350)等の吸光度計によりOD600を測定することにより求められる。
また、培養対象の腸内細菌が正しく培養されているかは、16SrDNAのシーケンス解析を公知の方法により行うことにより確認できる。
The viability of the enterobacteria is determined, for example, by measuring OD 600 using a spectrophotometer such as a Multiskan® GO microplate spectrophotometer (Thermo Fisher Scientific; product number 51119350).
Furthermore, whether the intestinal bacteria to be cultured have been cultured correctly can be confirmed by performing 16S rDNA sequence analysis using a known method.
次に、本発明の実施例に係る培地を用いた試験を通じて本発明をさらに詳述する。ただし、本発明は、以下の実施例に限定されるものではない。 Next, the present invention will be explained in further detail through a test using a culture medium according to an example of the present invention. However, the present invention is not limited to the following examples.
(実施例1)
前培養培地としてGAM液体培地とEG培地を体積比で1:1に混合したGE培地を用い、本培養培地としてGAM液体培地を用い、入手可能な欧米人腸内常在細菌叢最優勢45種(表1参照)を培養した。
前培養に用いるGE培地を形成するGAM液体培地、及び本培養に用いるGAM液体培地は、共に日水製薬株式会社製のGAMブイヨンを用いて指示書に従い調整した。
EG培地は、JCM(Japan Collection of Microorganisms)の指示書に従い作製した。EG培地のpHは、NaOHによりpH7.6から7.8の間に調整した。EG培地の組成を表3に示す。
GE培地は、嫌気チャンバー内でGAM液体培地とEG培地を100mLずつ混合して形成し、三菱ガス化学株式会社製アネロパックと共に密閉容器に入れ、4℃で保管した。
(Example 1)
Using GE medium, which is a mixture of GAM liquid medium and EG medium at a volume ratio of 1:1, as the pre-culture medium, and GAM liquid medium as the main culture medium, we collected the 45 most dominant bacterial flora that are available in Western human intestines. (see Table 1) was cultured.
The GAM liquid medium forming the GE medium used for preculture and the GAM liquid medium used for main culture were both prepared using GAM broth manufactured by Nissui Pharmaceutical Co., Ltd. according to the instructions.
EG medium was prepared according to the instructions of JCM (Japan Collection of Microorganisms). The pH of the EG medium was adjusted between pH 7.6 and 7.8 with NaOH. The composition of the EG medium is shown in Table 3.
The GE medium was formed by mixing 100 mL each of the GAM liquid medium and the EG medium in an anaerobic chamber, and the mixture was placed in an airtight container with an anero pack manufactured by Mitsubishi Gas Chemical Co., Ltd., and stored at 4°C.
欧米人腸内常在細菌叢最優勢45種の菌株は、表1に示した分譲機関から購入した。尚、表1の「占有順位」は欧米人人の腸内における占有順位である。 The 45 most predominant strains of bacterial flora native to the intestines of Westerners were purchased from the distributors listed in Table 1. The "occupancy ranking" in Table 1 indicates the occupancy ranking in the intestines of Westerners.
(前培養工程S1)
腸内細菌によって前培養に必要な時間が異なるため、予めEG寒天培地に欧米人腸内常在細菌叢最優勢45種の各腸内細菌を培養し、24時間ごとに生育度を観察して、各腸内細菌の前培養時間を求めた(表4参照)。これに基づき、腸内細菌ごとに本培養開始の24時間前、48時間前、96時間前に前培養を開始した。
まず、-80℃で保管された96時間で生育する細菌のグリセロールストックを、本培養開始時刻の96時間前に嫌気チャンバー内に移し、滅菌済みつまようじで当該グリセロースストックをかきとり、4mLバイアル瓶に予め分注しておいたGE培地3.5 mLに植菌した。
バイアル瓶中のGE培地と加えた菌体のグリセロールストックを、バイアル瓶を転倒することで混和し、アネロパックと共に密閉容器に入れ37℃で96時間培養した。
本培養開始48時間前と24時間前にも同様に細菌を植菌して培養した。
(Preculture step S1)
Since the time required for pre-culture differs depending on the intestinal bacteria, the 45 most dominant species of indigenous bacterial flora in the intestines of Europeans and Americans were cultured on EG agar medium in advance, and the growth rate was observed every 24 hours to determine the pre-culture time for each intestinal bacteria (see Table 4). Based on this, pre-culture was started for each intestinal bacteria 24 hours, 48 hours, and 96 hours before the start of main culture.
First, a glycerol stock of bacteria that had been stored at -80°C and was capable of growing for 96 hours was transferred into an anaerobic chamber 96 hours before the start of the main culture, and the glycerol stock was scraped off with a sterilized toothpick and inoculated into 3.5 mL of GE medium that had been dispensed in advance into a 4 mL vial.
The GE medium in the vial and the glycerol stock of the added bacterial cells were mixed by inverting the vial, and the mixture was placed in a sealed container together with an Anaeropack and cultured at 37° C. for 96 hours.
Bacteria were inoculated and cultured in the same manner 48 hours and 24 hours before the start of the main culture.
(本培養工程の準備)
嫌気条件下で保存した本培養のGAM培地を500μLずつ96穴ディープウェルプレート(丸穴丸底, 1.0mL; WATSON; 製品番号376-96R-10)のウェルにマルチチャンネルピペットマンを用いてリバースピペッティングで分注した。同時に1×PBS(-)を96穴ディープウェルプレート1枚に分注し、コピープレート96(株式会社トッケン; 製品番号TK-CPST)のピン先洗浄用プレートとした。これらの操作は嫌気チャンバー内で行った。
(Preparation for main culture process)
Using a multichannel pipetman, reverse-spill 500 μL of the main culture GAM medium stored under anaerobic conditions into the wells of a 96-well deep well plate (round hole, round bottom, 1.0 mL; WATSON; product number 376-96R-10). It was dispensed by petting. At the same time, 1×PBS(-) was dispensed into one 96-well deep well plate, and used as a plate for cleaning the pin tips of Copy Plate 96 (Tokken Co., Ltd.; product number TK-CPST). These operations were performed in an anaerobic chamber.
(本培養工程S2)
前培養工程により培養された腸内細菌を含む前培養液500μLを一旦96穴ディープウェルプレートに移した。96ウェルプレートに入った前培養液をマルチチャンネルピペットマンで10回ピペッティングすることで懸濁し、コピープレート96を前培養液のプレートに3秒押しこみ、これを本培養用プレートに3秒押しこんで接種した。コピープレート96をピン先洗浄用プレートで洗浄しながら、前培養液を3枚の本培養用の96ウェルプレートに接種した。接種済みの96ウェルプレートにGas Permeable Moisture Barrier Seal(4titude; 製品番号,4ti-0516/96)を貼付し、アネロパックと共に密閉容器に入れ、37℃で96時間培養した。
(Main culture step S2)
500 μL of the preculture solution containing enteric bacteria cultured in the preculture step was once transferred to a 96-well deep well plate. Suspend the preculture solution in the 96-well plate by pipetting it 10 times with a multichannel pipetman, push the copy plate 96 into the preculture solution plate for 3 seconds, and push this into the main culture plate for 3 seconds. It was inoculated with. While washing the copy plate 96 with a pin tip washing plate, the preculture solution was inoculated into three 96-well plates for main culture. Gas Permeable Moisture Barrier Seal (4titude; product number, 4ti-0516/96) was applied to the inoculated 96-well plate, placed in a sealed container with Aneropack, and cultured at 37°C for 96 hours.
(生育度の測定)
本培養工程の完了後、各腸内細菌の生育度は、OD600を指標に解析した。図1にその結果を示す。図中、生育度は3枚の96ウェルプレートから得られた平均値を示し、エラーバーは標準誤差を示す。
尚、生育度(OD600)は、光路長が10mmのキュベットを用いて測定した600 nmにおける吸光の測定値であるところ、本実施例では、96ウェルプレートを使用して培養液の600nmにおける吸光の測定値を測定しており、この96ウェルプレートの光路長は10mmとは異なるため、培養液をキュベット(ザルスタッド株式会社; 製品番号, 67.742J)に入れて吸光度を測定し、キュベットの吸光度 の値/プレートの吸光度の値(以下、「ファクタ」と呼ぶ。)を腸内細菌ごとに算出し、培養液をプレートで測定した際に出た値をファクタとかけることで、プレートで測定した値をキュベットで測定した値に換算した。
(Measurement of growth rate)
After the main culture process was completed, the growth rate of each enterobacteria was analyzed using OD600 as an index. The results are shown in Figure 1. In the figure, the growth rate is shown as the average value obtained from three 96-well plates, and the error bars indicate the standard error.
The degree of growth (OD 600 ) is the measured value of absorbance at 600 nm measured using a cuvette with an optical path length of 10 mm. In this embodiment, the measured value of absorbance of the culture solution at 600 nm was measured using a 96-well plate. Since the optical path length of this 96-well plate is different from 10 mm, the culture solution was placed in a cuvette (Sarsted Co., Ltd.; product number, 67.742J) and the absorbance was measured. The absorbance value of the cuvette/the absorbance value of the plate (hereinafter referred to as the "factor") was calculated for each enterobacteria. The value obtained when the culture solution was measured on the plate was multiplied by the factor to convert the value measured on the plate to the value measured on the cuvette.
(実施例2)
前培養培地としてGAM培地にウマの血液を混合したGB培地を用いた他は、実施例1と同様に、欧米人腸内常在細菌叢最優勢45種を培養し、培養した腸内細胞の生育度(OD600)を測定した。その結果を図1に示す。
GB培地に用いるGAM液体培地は、500mL容メディウム瓶に、GAMブイヨン11.8gとElix水を入れて190mLとし、スターラーバーとともに攪拌して完全に溶解させたのち、オートクレーブ(115℃、15分)して作製し、オートクレーブ内の温度が97℃まで下がるとすぐにアネロパック(三菱ガス化学株式会社;製品番号A-03)と共に密封容器に入れ、脱気処理しつつ常温で保存した。馬脱繊維血液(ジャパンバイオシーラム)は、予めファルコンチューブ(CORNNG; 製品番号430791)に分注し、アネロパックと共に密封容器に入れ、1日以上嫌気処理しておいた。嫌気処理後のウマの血液を嫌気チャンバー内でGAM培地に混合してGB培地を完成し、これをアネロパックと共に密封容器に入れて、使用直前まで4℃で保存した。表5にGB培地の組成を示す。
(Example 2)
In the same manner as in Example 1, except that GB medium, which is a mixture of GAM medium and horse blood, was used as a preculture medium, the 45 most dominant species of Western human intestinal flora were cultured, and the cultured intestinal cells were cultured. The degree of growth ( OD600 ) was measured. The results are shown in Figure 1.
For the GAM liquid medium used for the GB medium, put 11.8 g of GAM broth and Elix water in a 500 mL medium bottle to make 190 mL, stir with a stirrer bar to completely dissolve, and then autoclave (115 ° C., 15 minutes). As soon as the temperature inside the autoclave dropped to 97°C, it was placed in a sealed container with Anero Pack (Mitsubishi Gas Chemical Co., Ltd.; product number A-03) and stored at room temperature while being degassed. Horse defibrinated blood (Japan BioSealum) was dispensed in advance into Falcon tubes (CORNNG; product number 430791), placed in a sealed container with Aneropack, and subjected to anaerobic treatment for one day or more. Horse blood after anaerobic treatment was mixed with GAM medium in an anaerobic chamber to complete GB medium, which was placed in a sealed container with Aneropack and stored at 4°C until immediately before use. Table 5 shows the composition of the GB medium.
また、実施例2においては、前培養液から得られた菌体からgDNAを抽出し、16SrDNAのシーケンス解析を行い、結果をBLAST解析した。その結果、それぞれデータベース上の目的の細菌の16SrDNA配列と一致したことから、これらの生育がコンタミネーションの結果ではないことが確認できた。 In Example 2, gDNA was extracted from the bacterial cells obtained from the preculture solution, and 16SrDNA sequence analysis was performed, followed by BLAST analysis of the results. As a result, the 16SrDNA sequences matched those of the target bacteria in the database, confirming that the growth of these bacteria was not the result of contamination.
(比較例1)
前培養培地、本培養培地ともにGAM液体培地を用いた他は、実施例1と同様に、欧米人腸内常在細菌叢最優勢45種を培養し、培養した腸内細胞の生育度(OD600)を測定した。その結果を図1に示す。
(Comparative example 1)
In the same manner as in Example 1, except that GAM liquid medium was used for both the pre-culture medium and the main culture medium, the 45 most dominant bacterial flora resident in the Western human intestines were cultured, and the growth rate (OD) of the cultured intestinal cells was determined. 600 ) was measured. The results are shown in Figure 1.
(実施例3)
実施例2と同様に、前培養にGB培地、本培養にGAM液体培地を用いて欧米人腸内常在細菌叢最優勢45種の培養を行い、本培養開始後24時間ごとに生育度(OD600)を測定し、本培養工程における生育度の経時変化を調べた。その結果を図2-1、図2-2に示す。(1図にまとめると各グラフが小さくなるため、2図に分割して表示した。)
また、前培養完了時に得られた前培養液を用いて、16SrDNA解析を行った。
(Example 3)
In the same manner as in Example 2, 45 species of the most dominant bacterial flora resident in the Western human intestines were cultured using GB medium for preculture and GAM liquid medium for main culture, and the growth rate ( OD 600 ) was measured to examine changes in growth over time during the main culture step. The results are shown in Figures 2-1 and 2-2. (Since each graph would be smaller if combined into one figure, it was divided into two figures.)
Furthermore, 16S rDNA analysis was performed using the preculture solution obtained upon completion of the preculture.
(実施例4)
実施例2同様、前培養にGB培地を用い、本培養にGAM液体培地を用いて、入手可能な日本人腸内常在細菌叢最優勢15種(表6参照)を培養した。当該15種は、腸内常在細菌叢最優勢41種のうち、入手可能な欧米人腸内常在細菌叢最優勢45種と重複する26種を除いたものである。各腸内細菌の前培養時間は、予めGB平板培地に各細菌を植菌して、24時間ごとに形成されるコロニーを視認することで決定した(表6参照)。本培養時間は、実施例2では96時間であったが、本実施例ではEggerthella lentaを除き、48時間とし、Eggerthella lentaは、96時間とした。培養した各腸内細菌の生育度(OD600)を測定し、16SrDNA解析を行った。その結果を図3に示す。
As in Example 2, GB medium was used for pre-culture and GAM liquid medium was used for main culture to culture the 15 most dominant types of available Japanese intestinal flora (see Table 6). These 15 species are obtained by excluding 26 species out of the 41 most dominant intestinal flora species that overlap with the 45 most dominant intestinal flora species that are available. The preculture time for each enterobacterium was determined by inoculating each bacterium onto a GB plate medium in advance and visually observing the colonies formed every 24 hours (see Table 6). The main culture time was 96 hours in Example 2, but in this example, except for Eggerthella lenta, it was 48 hours, and for Eggerthella lenta, it was 96 hours. The degree of growth (OD 600 ) of each cultured intestinal bacteria was measured, and 16S rDNA analysis was performed. The results are shown in FIG.
(実施例5)
実施例2と同様に、前培養にGB培地を用い、本培養にGAM液体培地を用いて、表7に示した重要腸内細菌(プロバイオティクス細菌、酪酸酸性菌、悪玉菌が含まれる。)を培養した。培養時間は、以下の3通りとした。
(1)GB培地を用いた前培養24時間→GAM培地を用いた本培養24時間
(2)GB培地を用いた前培養24時間→GAM培地を用いた本培養48時間
(3)GB培地を用いた前培養48時間→GAM培地を用いた本培養24時間
As in Example 2, the important intestinal bacteria (including probiotic bacteria, butyric acid bacteria, and harmful bacteria) shown in Table 7 were cultured using GB medium for pre-culture and GAM liquid medium for main culture. The culture time was set to the following three times.
(1) Preculture using GB medium for 24 hours → Main culture using GAM medium for 24 hours (2) Preculture using GB medium for 24 hours → Main culture using GAM medium for 48 hours (3) Preculture using GB medium for 48 hours → Main culture using GAM medium for 24 hours
(実施例9)
本培養培地として、GAM液体培地とEGMB培地を混合した(GAM+EGMB)培地を用いた他は、実施例8と同様にして欧米人腸内常在細菌叢最優勢45種の培養を行って生育度を測定した。
(GAM+EGMB)培地は、GAM培地(実施例1参照)と、EGMB培地(実施例8参照)を100mLずつ嫌気チャンバー内で混合し、アネロパックと共に密閉容器に入れ常温で保存した。
Example 9
The main culture medium was a mixture of GAM liquid medium and EGMB medium (GAM+EGMB), but the same procedure as in Example 8 was used to culture the 45 most predominant species of bacterial flora commonly found in the intestines of Europeans and Americans, and measure their growth rates.
To prepare the (GAM+EGMB) medium, 100 mL each of GAM medium (see Example 1) and EGMB medium (see Example 8) was mixed in an anaerobic chamber, placed in an airtight container together with an Anaeropack, and stored at room temperature.
(結果)
(実施例1、実施例2、比較例1の結果)
図1に示すように、前培養、本培養ともにGAM培地を用いた比較例1では、欧米人腸内常在細菌叢最優勢45種のうち36種(図1中の符号Bを付した白丸参照)のみが生育したのに対し、前培養にEG培地を用いた実施例1は、当該45種中40種、前培養にGB培地を用いた実施例2の場合は、当該45種中39種が十分に生育することが分かった(図1中の符号C、Dを付した灰色、及び黒丸参照)。
(result)
(Results of Example 1, Example 2, and Comparative Example 1)
As shown in FIG. 1 , in Comparative Example 1 in which GAM medium was used for both pre-culture and main culture, only 36 of the 45 most dominant species of bacterial flora normally present in the intestines of Europeans and Americans (see the white circles marked with the symbol B in FIG. 1 ) grew, whereas in Example 1 in which EG medium was used for pre-culture, 40 of the 45 species grew sufficiently, and in Example 2 in which GB medium was used for pre-culture, 39 of the 45 species grew sufficiently (see the gray and black circles marked with the symbols C and D in FIG. 1 ).
(実施例3の結果)
実施例2同様、前培養培地にGB培地を用い、本培養培地にGAM液体培地を用いて、本培養時の菌の生育度を24時間ごとに測定したところ、図2-1、図2-2に示すように、入手可能な欧米人常在腸内細菌45種のうち、実施例2で飼育した菌のうち2種が生育しなかった一方で、実施例2で生育しなかった1種について安定した増殖が確認され、都合39菌種が継続的増殖を示すことが分かった。培養した菌の16SrDNA解析により、増殖した39種すべての菌について、確実に増殖していることが確認できた。
(Results of Example 3)
As in Example 2, using GB medium as the pre-culture medium and GAM liquid medium as the main culture medium, the growth rate of bacteria during main culture was measured every 24 hours. As shown in Figure 2, among the 45 types of available Western intestinal bacteria, two of the bacteria reared in Example 2 did not grow, while one species did not grow in Example 2. It was confirmed that 39 bacterial species showed continuous growth. 16S rDNA analysis of the cultured bacteria confirmed that all 39 types of bacteria were growing reliably.
(実施例4の結果)
前培養培地にGB培地を用い、本培養培地にGAM液体培地を用いて、入手可能な日本人腸内常在細菌叢最優勢15種について培養を行ったところ、図3に示すように、14種について十分な生育度(OD600が0.15以上)が得られたが、このうち2種は、16SrDNA解析により正しい菌が培養されたことが確認できなかった。従って、当該15種のうち、12種が培養可能であることが分かった。
(Results of Example 4)
Using GB medium as the preculture medium and GAM liquid medium as the main culture medium, we cultured the 15 most dominant species of Japanese intestinal flora that were available, as shown in Figure 3. Although a sufficient growth rate (OD 600 of 0.15 or more) was obtained for the seeds, it could not be confirmed by 16S rDNA analysis that the correct bacteria had been cultured for two of the seeds. Therefore, it was found that 12 of the 15 species could be cultured.
(実施例5の結果)
前培養にGB培地を用い、本培養にGAM液体培地を用いて、表9に示した重要腸内細菌25種について培養を行ったところ25種すべてについて、十分な生育度が得られ(OD600が0.15以上)培養に成功した。前培養をGAM培地で行った場合と比較して培養可能な菌種数に変化はなかったが、3菌種について前培養時間が48時間から24時間に短縮された(表9参照)。
When 25 important enterobacteria species shown in Table 9 were cultured using GB medium for pre-culture and GAM liquid medium for main culture, sufficient growth was obtained for all 25 species (OD 600 was 0.15 or more) and they were successfully cultured. There was no change in the number of culturable species compared to when pre-culture was performed in GAM medium, but the pre-culture time for three species was shortened from 48 hours to 24 hours (see Table 9).
(実施例6の結果)
前培養培地として、ヒツジの血液を5%(v/v)添加したGB(sheep)培地を用い、本培養培地としてGAM培地を用い、実施例3で培養可能であった入手可能な欧米人腸内常在細菌叢最優勢45種のうちの39種と、実施例4で培養可能であった入手可能な日本人腸内常在細菌のうちの12種を合わせた51種について培養試験を行ったところ、図5に示すように、48種について十分な生育度(OD600が0.15以上)が得られた。
(Results of Example 6)
GB (sheep) medium supplemented with 5% (v/v) sheep blood was used as the preculture medium, and GAM medium was used as the main culture medium. A culture test was performed on 51 species, including 39 species out of the 45 most dominant species of indigenous bacterial flora in Europeans and Americans that could be cultured in Example 3 and 12 species out of the 12 species out of the indigenous bacterial flora in Japanese people that could be cultured in Example 4, and as shown in Figure 5, sufficient growth (OD 600 of 0.15 or more) was obtained for 48 species.
(実施例7の結果)
前培養培地として、ヒトの血液を5%(v/v)添加したGB(human)培地を用いた他は実施例6と同様にして字四位例6と同じ51種の腸内細菌について培養試験を行ったところ、図6に示すように、45種について十分な生育度(OD600が0.15以上)が得られた。
(Results of Example 7)
The same 51 types of intestinal bacteria as in Example 6 were cultured in the same manner as in Example 6, except that GB (human) medium supplemented with 5% (v/v) human blood was used as the preculture medium. When the test was conducted, as shown in FIG. 6, sufficient growth (OD 600 of 0.15 or more) was obtained for 45 species.
(実施例8、実施例9の結果)
前培養にEG培地を用い、本培養にEGMBを用いて、欧米人腸内常在細菌叢最優勢45種の培養を行ったところ、図6に示すように39種について、十分な生育度(OD600が0.15以上)が得られ、前培養にEG培地を用い、本培養に(EGMB+GAM)培地を用いて、欧米人腸内常在細菌叢最優勢45種の培養を行ったところ、図6に示すように40種について、十分な生育度(OD600が0.15以上)が得られた。
(Results of Example 8 and Example 9)
Using EG medium for preculture and EGMB for main culture, we cultured the 45 most dominant species of Western human intestinal flora, and as shown in Figure 6, 39 species showed sufficient growth ( OD 600 of 0.15 or higher) was obtained, and the 45 most dominant species of Western human intestinal flora were cultured using EG medium for preculture and (EGMB+GAM) medium for main culture. However, as shown in FIG. 6, sufficient growth (OD 600 of 0.15 or more) was obtained for 40 species.
以上、本発明の培地は、上記の実施形態に限られず、例えば、本培養培地は、GAM培地、EGMB培地、又はGAM培地とEGMB培地を混合した培地以外の培地を用いてもよい。GAM培地に加える哺乳動物の血液としては、ウマ、ヒツジ、ヒトに限らず公知の哺乳動物の血液を適宜に用いることができる。また、複数種の哺乳動物の血液を同時に添加してもよい。哺乳動物の血液をGAM培地に加える体積濃度は、2.0%(v/v)未満であってもよいし6.0%(v/v)を超えてもよい。 As described above, the medium of the present invention is not limited to the above embodiments, and for example, the main culture medium may be a medium other than GAM medium, EGMB medium, or a mixed medium of GAM medium and EGMB medium. The mammalian blood to be added to the GAM medium is not limited to horse, sheep, and human blood, and any known mammalian blood can be used as appropriate. Furthermore, blood from multiple types of mammals may be added at the same time. The volumetric concentration of mammalian blood added to the GAM medium may be less than 2.0% (v/v) or greater than 6.0% (v/v).
上記課題を解決するためになされた発明は、ヒトの腸内細菌の培養を行うために用いる、前培養培地と本培養培地とからなる腸内細菌培養組培地であって、前培養培地がGAMブイヨンから形成したGAM液体培地に、ウマ、ヒツジ、又はヒトの血液を加えた培地からなり、前記血液の体積濃度が2.0%以上、6.0%(v/v)以下であり、本培養培地がGAMブイヨンから形成したGAM液体培地からなり、
Bacteroides uniformis、Parabacteroides merdae、Dorea longicatena、Ruminococcus bromii、Bacteroides caccae、Bacteroides thetaiotaomicron、Ruminococcus torques、Ruminococcus lactaris、Collinsella aerofaciens、Dorea formicigenerans、Roseburia intestinalis、Parabacteroides distasonis、Bacteroides ovatus、Eubacterium rectale、Bacteroides xylanisolvens、Coprococcus comes、Eubacterium ventriosum、Bacteroide dorei、Ruminococcus obeum、Subdoligranulum variabile、Pseudoflavonifractor capillosus、Holdemania filiformis、Bacteroides stercoris、Bacteroides eggerthii、Butyrivibrio crossotus、Bacteroides finegoldii、Parabacteroides johnsonii、Clostridium nexile、Anaerotruncus colihominis、Ruminococcus gnavus、Bacteroides intestinalis、Bacteroides fragilis、Clostridium asparagiforme、Enterococcus Faecalis、Clostridium scindens、及びBlautia hanseniiからなる群のうち、Ruminococcus bromii、Eubacterium rectale、Subdoligranulum variabile、Holdemania filiformis、及びButyrivibrio crossotusからなる群から選ばれた少なくとも一種の菌を含む複数の菌を同時に培養可能であることを特徴とする。
The invention made to solve the above problems is an enterobacteriaceae culture set medium consisting of a preculture medium and a main culture medium used for culturing human enterobacteria, the preculture medium being GAM. The medium consists of a GAM liquid medium formed from bouillon and horse, sheep, or human blood, and the volume concentration of the blood is 2.0% or more and 6.0% (v/v) or less; the culture medium consists of a GAM liquid medium formed from GAM broth;
Bacteroides uniformis, Parabacteroides merdae, Dorea longicatena, Ruminococcus bromii, Bacteroides caccae, Bacteroides thetaiotaomicron, Ruminococcus torques, Ruminococcus lactaris, Collinsella aerofaciens, Dorea formicigenerans, Roseburia intestinalis, Parabacteroides distasonis, Bacteroides ovatus, Eubacterium rectale, Bacteroides ides xylanisolvens, Coprococcus comes, Eubacterium ventriosum , Bacteroides dorei, Ruminococcus obeum, Subdoligranulum variabile, Pseudoflavonifractor capillosus, Holdemania filiformis, Bacteroides stercoris, Bacteroides eggerthii, Butyrivibrio crossotus, Bacteroides finegoldii, Parabacteroides johnsonii, Clostridium nexile, Anaerotruncus colihominis, Ruminococcus gnavus, Bacteroides intestinalis, Bacteroides fragilis, Clostridium asparagiforme, Enterococcus It is possible to simultaneously culture multiple bacteria including at least one type of bacteria selected from the group consisting of Faecalis, Clostridium scindens, and Blautia hansenii, Ruminococcus bromii, Eubacterium rectale, Subdoligranulum variabile, Holdemania filiformis, and Butyrivibrio crossotus. characterized by something.
本発明の腸内細菌前培養組培地は、このようにGAM系培地にウマ、ヒツジ、又はヒトの血液を2.0%以上、6.0%(v/v)以下の体積濃度で添加した前培養培地を用いたので、多くの種類の腸内細菌を同時に培養することができる。 The enterobacteria preculture medium of the present invention uses a preculture medium in which horse, sheep, or human blood has been added to a GAM-based medium at a volume concentration of 2.0% or more and 6.0% or less (v/v) , so that many types of enterobacteria can be cultured simultaneously.
本発明の腸内細菌培養組培地は、Ruminococcus bromii、Eubacterium rectale、Subdoligranulum variabile、Holdemania filiformis、及びButyrivibrio crossotusを同時に培養可能なことが好ましい。 The enteric bacteria culture medium of the present invention is preferably capable of simultaneously cultivating Ruminococcus bromii, Eubacterium rectale, Subdoligranulum variabile, Holdemania filiformis, and Butyrivibrio crossotus.
本発明の腸内細菌培養組培地は、Bacteroides uniformis、Parabacteroides merdae、Dorea longicatena、Ruminococcus bromii、Bacteroides caccae、Bacteroides thetaiotaomicron、Ruminococcus torques、Ruminococcus lactaris、Collinsella aerofaciens、Dorea formicigenerans、Roseburia intestinalis、Parabacteroides distasonis、Bacteroides ovatus、Eubacterium rectale、Bacteroides xylanisolvens、Coprococcus comes、Eubacterium ventriosum、Bacteroide dorei、Ruminococcus obeum、Subdoligranulum variabile、Pseudoflavonifractor capillosus、Holdemania filiformis、Bacteroides stercoris、Bacteroides eggerthii、Butyrivibrio crossotus、Bacteroides finegoldii、Parabacteroides johnsonii、Clostridium nexile、Anaerotruncus colihominis、Ruminococcus gnavus、Bacteroides intestinalis、Bacteroides fragilis、Clostridium asparagiforme、Enterococcus Faecalis、Clostridium scindens、及びBlautia hanseniiを全て同時に培養可能なことが好ましい。The enterobacteria culture medium of the present invention is selected from the group consisting of Bacteroides uniformis, Parabacteroides merdae, Dorea longicatena, Ruminococcus bromii, Bacteroides caccae, Bacteroides thetaiotaomicron, Ruminococcus torques, Ruminococcus lactaris, Collinsella aerofaciens, Dorea formicigenerans, Roseburia intestinalis, Parabacteroides distasonis, Bacteroides ovatus, Eubacterium rectale, Bacteroides xylanisolvens, Coprococcus comes, Eubacterium ventriosum, Bacteroides dorei, Ruminococcus obeum, Subdoligranulum variabile, Pseudoflavonifractor capillosus, Holdemania filiformis, Bacteroides stercoris, Bacteroides eggerthii, Butyrivibrio crossotus, Bacteroides finegoldii, Parabacteroides Preferably, the following bacteria can all be cultured simultaneously: Clostridium johnsonii, Clostridium nexile, Anaerotruncus colihominis, Ruminococcus gnavus, Bacteroides intestinalis, Bacteroides fragilis, Clostridium asparagiforme, Enterococcus faecalis, Clostridium scindens, and Blautia hansenii.
本発明は、ヒトの腸内細菌の培養を行うために用いる、前培養培地と本培養培地とからなる腸内細菌培養組培地を用いて、腸内細菌の培養を行う腸内細菌培養方法であって、 前培養培地がGAMブイヨンから形成したGAM液体培地に、ウマ、ヒツジ、又はヒトの血液を加えた培地からなり、前記血液の体積濃度が2.0%以上、6.0%(v/v)以下であり、本培養培地がGAMブイヨンから形成したGAM液体培地からなり、
Bacteroides uniformis、Parabacteroides merdae、Dorea longicatena、Ruminococcus bromii、Bacteroides caccae、Bacteroides thetaiotaomicron、Ruminococcus torques、Ruminococcus lactaris、Collinsella aerofaciens、Dorea formicigenerans、Roseburia intestinalis、Parabacteroides distasonis、Bacteroides ovatus、Eubacterium rectale、Bacteroides xylanisolvens、Coprococcus comes、Eubacterium ventriosum、Bacteroide dorei、Ruminococcus obeum、Subdoligranulum variabile、Pseudoflavonifractor capillosus、Holdemania filiformis、Bacteroides stercoris、Bacteroides eggerthii、Butyrivibrio crossotus、Bacteroides finegoldii、Parabacteroides johnsonii、Clostridium nexile、Anaerotruncus colihominis、Ruminococcus gnavus、Bacteroides intestinalis、Bacteroides fragilis、Clostridium asparagiforme、Enterococcus Faecalis、Clostridium scindens、及びBlautia hanseniiからなる群のうち、Ruminococcus bromii、Eubacterium rectale、Subdoligranulum variabile、Holdemania filiformis、及びButyrivibrio crossotusからなる群から選ばれた少なくとも一種の菌を含む複数の菌を同時に培養することを特徴とする腸内細菌培養方法を含む。
The present invention is a method for culturing enterobacteria, which involves culturing enterobacteria using an enterobacteria culture medium consisting of a pre-culture medium and a main culture medium, which is used for culturing human enterobacteria. The preculture medium consists of a GAM liquid medium formed from GAM broth and horse, sheep, or human blood added thereto, and the volume concentration of the blood is 2.0% or more, 6.0% (v /v) and the main culture medium consists of a GAM liquid medium formed from GAM broth,
Bacteroides uniformis, Parabacteroides merdae, Dorea longicatena, Ruminococcus bromii, Bacteroides caccae, Bacteroides thetaiotaomicron, Ruminococcus torques, Ruminococcus lactaris, Collinsella aerofaciens, Dorea formicigenerans, Roseburia intestinalis, Parabacteroides distasonis, Bacteroides ovatus, Eubacterium rectale, Bacteroides ides xylanisolvens, Coprococcus comes, Eubacterium ventriosum , Bacteroides dorei, Ruminococcus obeum, Subdoligranulum variabile, Pseudoflavonifractor capillosus, Holdemania filiformis, Bacteroides stercoris, Bacteroides eggerthii, Butyrivibrio crossotus, Bacteroides finegoldii, Parabacteroides johnsonii, Clostridium nexile, Anaerotruncus colihominis, Ruminococcus gnavus, Bacteroides intestinalis, Bacteroides fragilis, Clostridium asparagiforme, Enterococcus Cultivating simultaneously a plurality of bacteria including at least one type of bacteria selected from the group consisting of Ruminococcus bromii, Eubacterium rectale, Subdoligranulum variabile, Holdemania filiformis, and Butyrivibrio crossotus among the group consisting of Faecalis, Clostridium scindens, and Blautia hansenii. Including a method for culturing intestinal bacteria characterized by :
本発明の腸内細菌培養方法は、Ruminococcus bromii、Eubacterium rectale、Subdoligranulum variabile、Holdemania filiformis、及びButyrivibrio crossotusを同時に培養することが好ましい。In the intestinal bacteria culture method of the present invention, it is preferable to simultaneously culture Ruminococcus bromii, Eubacterium rectale, Subdoligranulum variabile, Holdemania filiformis, and Butyrivibrio crossotus.
本発明の腸内細菌培養方法は、Bacteroides uniformis、Parabacteroides merdae、Dorea longicatena、Ruminococcus bromii、Bacteroides caccae、Bacteroides thetaiotaomicron、Ruminococcus torques、Ruminococcus lactaris、Collinsella aerofaciens、Dorea formicigenerans、Roseburia intestinalis、Parabacteroides distasonis、Bacteroides ovatus、Eubacterium rectale、Bacteroides xylanisolvens、Coprococcus comes、Eubacterium ventriosum、Bacteroide dorei、Ruminococcus obeum、Subdoligranulum variabile、Pseudoflavonifractor capillosus、Holdemania filiformis、Bacteroides stercoris、Bacteroides eggerthii、Butyrivibrio crossotus、Bacteroides finegoldii、Parabacteroides johnsonii、Clostridium nexile、Anaerotruncus colihominis、Ruminococcus gnavus、Bacteroides intestinalis、Bacteroides fragilis、Clostridium asparagiforme、Enterococcus Faecalis、Clostridium scindens、及びBlautia hanseniiを全て同時に培養することが好ましい。The intestinal bacteria culture method of the present invention includes Bacteroides uniformis, Parabacteroides merdae, Dorea longicatena, Ruminococcus bromii, Bacteroides caccae, Bacteroides thetaiotaomicron, Ruminococcus torques, Ruminococcus lactaris, Collinsella aerofaciens, Dorea formicigenerans, Roseburia intestinalis, Parabacteroides distasonis, Bacteroides ovatus, Eub acterium rectale, Bacteroides xylanisolvens, Coprococcus comes, Eubacterium ventriosum, Bacteroide dorei, Ruminococcus obeum, Subdoligranulum variabile, Pseudoflavonifractor capillosus, Holdemania filiformis, Bacteroides stercoris, Bacteroides eggerthii, Butyrivibrio crossotus, Bacteroides finegoldii, Parabacteroides johnsonii , Clostridium nexile, Anaerotruncus colihominis, Ruminococcus gnavus, Preferably, Bacteroides intestinalis, Bacteroides fragilis, Clostridium asparagiforme, Enterococcus Faecalis, Clostridium scindens, and Blautia hansenii are all cultured simultaneously.
このように、本発明の腸内細菌培養組培地、及び腸内細菌培養方法によれば、多くの種の腸内細菌を同時に培養することができる。 Thus, according to the enterobacteria culture medium and the enterobacteria culture method of the present invention, many species of enterobacteria can be cultured simultaneously.
以下、実施例1、実施例8、実施例9は、それぞれ参考例1、参考例8、参考例9と読み替える。
(実施例1)
前培養培地としてGAM液体培地とEG培地を体積比で1:1に混合したGE培地を用
い、本培養培地としてGAM液体培地を用い、入手可能な欧米人腸内常在細菌叢最優勢4
5種(表1参照)を培養した。
前培養に用いるGE培地を形成するGAM液体培地、及び本培養に用いるGAM液体培
地は、共に日水製薬株式会社製のGAMブイヨンを用いて指示書に従い調整した。
EG培地は、JCM(Japan Collection of Microorga
nisms)の指示書に従い作製した。EG培地のpHは、NaOHによりpH7.6か
ら7.8の間に調整した。EG培地の組成を表3に示す。
GE培地は、嫌気チャンバー内でGAM液体培地とEG培地を100mLずつ混合して
形成し、三菱ガス化学株式会社製アネロパックと共に密閉容器に入れ、4℃で保管した。
Hereinafter, Example 1, Example 8, and Example 9 will be read as Reference Example 1, Reference Example 8, and Reference Example 9, respectively.
(Example 1)
Using GE medium, which is a mixture of GAM liquid medium and EG medium at a volume ratio of 1:1, as the pre-culture medium, and GAM liquid medium as the main culture medium, we used the most dominant bacterial flora in the Western human intestines available.
Five species (see Table 1) were cultured.
The GAM liquid medium forming the GE medium used for preculture and the GAM liquid medium used for main culture were both prepared using GAM broth manufactured by Nissui Pharmaceutical Co., Ltd. according to the instructions.
EG medium is JCM (Japan Collection of Microorga)
nisms). The pH of the EG medium was adjusted between pH 7.6 and 7.8 with NaOH. The composition of the EG medium is shown in Table 3.
The GE medium was formed by mixing 100 mL each of GAM liquid medium and EG medium in an anaerobic chamber, placed in a sealed container together with Mitsubishi Gas Chemical Co., Ltd.'s Anero Pack, and stored at 4°C.
(実施例5)
実施例2と同様に、前培養にGB培地を用い、本培養にGAM液体培地を用いて、表7に示した重要腸内細菌(プロバイオティクス細菌、酪酸酸性菌、悪玉菌が含まれる。)を培養した。培養時間は、以下の3通りとした。
(1)GB培地を用いた前培養24時間→GAM培地を用いた本培養24時間
(2)GB培地を用いた前培養24時間→GAM培地を用いた本培養48時間
(3)GB培地を用いた前培養48時間→GAM培地を用いた本培養24時間
前培地として、GAM培地にヒツジの血液を5%(v/v)添加したGB(sheep)培地を用いて、入手可能な欧米人腸内常在細菌叢最優勢種と、入手可能な日本人腸内常在細菌について、培養試験を行った。本培養時間は、48時間とした。測定した各腸内細菌の生育度(OD600)を図5に示す。
(実施例7)
前培地として、GAM培地にヒトの血液を5%(v/v)添加したGB(human)培地を用いて、実施例6と同じ腸内細菌について実施例6と同様に培養試験を行って、培養した各腸内細菌の生育度(OD600)を測定した。その結果を、図6に示す。
(実施例8)
前培養培地として実施例1で用いたEG培地を用い、本培養培地としてEG培地から馬無菌脱繊血を除去した表8に記載のEGMB培地を用い、入手可能な欧米人腸内常在細菌叢最優勢45種の培養を行った。
As in Example 2, GB medium was used for pre-culture and GAM liquid medium was used for main culture, and the important intestinal bacteria shown in Table 7 (including probiotic bacteria, butyric acid bacteria, and bad bacteria) were cultured. ) was cultured. The culture time was set to the following three types.
(1) 24 hours of pre-culture using GB medium → 24 hours of main culture using GAM medium (2) 24 hours of pre-culture using GB medium → 48 hours of main culture using GAM medium (3) Main culture using GB medium 48 hours of preculture using → 24 hours of main culture using GAM medium
As a pre-culture medium, GB (sheep) medium, which is a GAM medium supplemented with 5% (v/v) sheep blood, was used to prepare the most dominant species of Western human intestinal flora available and the available Japanese. Culture tests were conducted on resident intestinal bacteria. The main culture time was 48 hours. The measured growth degree (OD600) of each intestinal bacteria is shown in FIG.
(Example 7)
A culture test was conducted in the same manner as in Example 6 on the same intestinal bacteria as in Example 6, using GB (human) medium in which 5% (v/v) human blood was added to GAM medium as a pre-medium. The degree of growth (OD600) of each cultured intestinal bacteria was measured. The results are shown in FIG.
(Example 8)
The EG medium used in Example 1 was used as a pre-culture medium, and the EGMB medium listed in Table 8, obtained by removing horse sterile defibrinated blood from the EG medium, was used as the main culture medium. The 45 most dominant species were cultured.
(結果)
(実施例1、実施例2、比較例1の結果)
図1に示すように、前培養、本培養ともにGAM培地を用いた比較例1では、欧米人腸内常在細菌叢最優勢45種のうち36種(図1中の符号Bを付した白丸参照)のみが生育したのに対し、前培養にGE培地を用いた実施例1は、当該45種中40種、前培養にGB培地を用いた実施例2の場合は、当該45種中39種が十分に生育することが分かった(図1中の符号C、Dを付した灰色、及び黒丸参照)。
(result)
(Results of Example 1, Example 2, and Comparative Example 1)
As shown in FIG. 1 , in Comparative Example 1, in which GAM medium was used for both pre-culture and main culture, only 36 of the 45 most dominant species of bacterial flora normally present in the intestines of Europeans and Americans (see the white circles marked with the symbol B in FIG. 1 ) grew, whereas in Example 1, in which GE medium was used for pre-culture, 40 of the 45 species grew sufficiently, and in Example 2, in which GB medium was used for pre-culture, 39 of the 45 species grew sufficiently (see the gray and black circles marked with the symbols C and D in FIG. 1 ).
(実施例7の結果)
前培養培地として、ヒトの血液を5%(v/v)添加したGB(human)培地を用いた他は実施例6と同様にして実施例6と同じ51種の腸内細菌について培養試験を行ったところ、図6に示すように、45種について十分な生育度(OD600が0.15以上)が得られた。
(Results of Example 7)
Cultivation tests were carried out on the same 51 species of enterobacteria as in Example 6 in the same manner as in Example 6, except that GB (human) medium supplemented with 5% (v/v) human blood was used as the preculture medium. As a result, as shown in FIG. 6, sufficient growth (OD 600 of 0.15 or more) was obtained for 45 species.
(実施例8、実施例9の結果)
前培養にEG培地を用い、本培養にEGMBを用いて、欧米人腸内常在細菌叢最優勢45種の培養を行ったところ、図7に示すように39種について、十分な生育度(OD600が0.15以上)が得られ、前培養にEG培地を用い、本培養に(EGMB+GAM)培地を用いて、欧米人腸内常在細菌叢最優勢45種の培養を行ったところ、図6に示すように40種について、十分な生育度(OD600が0.15以上)が得られた。
(Results of Example 8 and Example 9)
Using EG medium for preculture and EGMB for main culture, we cultured the 45 most dominant species of Western human intestinal flora, and as shown in Figure 7 , 39 species showed sufficient growth ( OD 600 of 0.15 or higher) was obtained, and the 45 most dominant species of Western human intestinal flora were cultured using EG medium for preculture and (EGMB+GAM) medium for main culture. However, as shown in FIG. 6, sufficient growth (OD 600 of 0.15 or more) was obtained for 40 species.
Claims (9)
GAM系培地に哺乳動物の血液を添加してなる腸内細菌前培養培地。 An intestinal bacteria pre-culture medium that can be used for pre-culture before main culture of human intestinal bacteria using the main culture medium,
An enterobacteria pre-culture medium comprising a GAM-based medium to which mammalian blood has been added.
GAM系培地、EG培地から馬無菌脱繊血を除去したEGMB培地、又はGAM系培地とEGMB培地を混合した培地からなる腸内細菌本培養培地と
を備える腸内細菌培養組培地。 The enterobacteria preculture medium according to claim 1,
An enterobacteria culture medium comprising a GAM-based medium, an EGMB medium obtained by removing sterile defibrated horse blood from an EG medium, or an enterobacteria main culture medium consisting of a medium obtained by mixing a GAM-based medium and an EGMB medium.
を備えることを特徴とする腸内細菌培養方法。 A method for culturing intestinal bacteria, comprising a pre-culture step of pre-culturing intestinal bacteria using a GAM-based medium containing added mammalian blood, and a main culture step of culturing the intestinal bacteria cultured in the pre-culture step using a main culture medium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022150537A JP7279983B1 (en) | 2022-09-21 | 2022-09-21 | An intestinal bacteria culture medium and an intestinal bacteria culture method. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022150537A JP7279983B1 (en) | 2022-09-21 | 2022-09-21 | An intestinal bacteria culture medium and an intestinal bacteria culture method. |
Publications (2)
Publication Number | Publication Date |
---|---|
JP7279983B1 JP7279983B1 (en) | 2023-05-23 |
JP2024044791A true JP2024044791A (en) | 2024-04-02 |
Family
ID=86395891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022150537A Active JP7279983B1 (en) | 2022-09-21 | 2022-09-21 | An intestinal bacteria culture medium and an intestinal bacteria culture method. |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7279983B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006328052A (en) * | 2005-04-25 | 2006-12-07 | Meguro Kenkyusho:Kk | Composition for disinfecting porphyromonas gingivalis |
US20160040215A1 (en) * | 2013-03-14 | 2016-02-11 | Seres Therapeutics, Inc. | Methods for Pathogen Detection and Enrichment from Materials and Compositions |
JP2016519664A (en) * | 2013-03-15 | 2016-07-07 | セレス セラピューティクス インコーポレイテッド | Microbial composition and method based on network |
JP2017515890A (en) * | 2014-04-10 | 2017-06-15 | 国立研究開発法人理化学研究所 | Compositions and methods for the induction of Th17 cells |
CN110093276A (en) * | 2019-06-03 | 2019-08-06 | 新乡医学院 | A kind of method of directional selectivity separation enteric bacteria |
WO2019235447A1 (en) * | 2018-06-04 | 2019-12-12 | 味の素株式会社 | Bacterium inducing diabetes |
-
2022
- 2022-09-21 JP JP2022150537A patent/JP7279983B1/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006328052A (en) * | 2005-04-25 | 2006-12-07 | Meguro Kenkyusho:Kk | Composition for disinfecting porphyromonas gingivalis |
US20160040215A1 (en) * | 2013-03-14 | 2016-02-11 | Seres Therapeutics, Inc. | Methods for Pathogen Detection and Enrichment from Materials and Compositions |
JP2016519664A (en) * | 2013-03-15 | 2016-07-07 | セレス セラピューティクス インコーポレイテッド | Microbial composition and method based on network |
JP2017515890A (en) * | 2014-04-10 | 2017-06-15 | 国立研究開発法人理化学研究所 | Compositions and methods for the induction of Th17 cells |
WO2019235447A1 (en) * | 2018-06-04 | 2019-12-12 | 味の素株式会社 | Bacterium inducing diabetes |
CN110093276A (en) * | 2019-06-03 | 2019-08-06 | 新乡医学院 | A kind of method of directional selectivity separation enteric bacteria |
Non-Patent Citations (2)
Title |
---|
NATURE MICROBIOLOGY, 2018, VOL.3, PP.514-522, JPN6022049888, ISSN: 0005008550 * |
感染症学会雑誌, 1971, VOL.45, NO.9, PP.406-419, JPN6022049887, ISSN: 0005008549 * |
Also Published As
Publication number | Publication date |
---|---|
JP7279983B1 (en) | 2023-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Achtman et al. | Genomic diversity of Salmonella enterica-The UoWUCC 10K genomes project | |
Lin et al. | The evolution of ecological facilitation within mixed-species biofilms in the mouse gastrointestinal tract | |
Cosetta et al. | Deconstructing and reconstructing cheese rind microbiomes for experiments in microbial ecology and evolution | |
RU2573934C2 (en) | Method for obtaining bacteriophage strain, specific strains of bacteriophages and their application | |
Wornell et al. | High‐throughput Method for Novel Medium Development for Culture of Anaerobic Gut Bacteria | |
Kessler et al. | In situ, in vivo, and in vitro approaches for studying AMR plasmid conjugation in the gut microbiome | |
JP7279983B1 (en) | An intestinal bacteria culture medium and an intestinal bacteria culture method. | |
Abildgaard et al. | Sequence variation in the α-toxin encoding plc gene of Clostridium perfringens strains isolated from diseased and healthy chickens | |
Farmer et al. | Urinary tract infection Escherichia coli is related to the environmental Escherichia coli in their DNA barcoding and antibiotic resistance patterns in Grenada | |
Kelley et al. | Isolation and Whole‐Genome Sequencing of Environmental Campylobacter | |
Son et al. | Genetic screens and biochemical assays to characterize Vibrio cholerae O1 Biotypes: classical and El Tor | |
Akhlaghi et al. | Prevalence and antibiotic resistance of Helicobacter pullorum isolates in poultry from Semnan province, Iran | |
Park et al. | Detection Strategies for Foodborne Salmonella and Prospects for Utilization of Whole Genome Sequencing Approaches | |
Taher et al. | Isolation and identification normal flora bacteria from different areas of Ninava governorate | |
CN109517915A (en) | The dry powdered LAMP quick detection kit of vibrio alginolyticus | |
Alomari et al. | Multi-locus sequences Technique for Identified Lactobacillus salivarius from Greek yogurt anti-biofilm agents | |
Ajayi et al. | Molecular Identification of Selected Multiple Antibiotic Resistance Bacteria Isolated from Poultry Droppings in Akure, Nigeria | |
JP7538125B2 (en) | Methods for detecting and enumerating low levels of Listeria | |
US9458490B2 (en) | Method and apparatus for collecting representative microbiological water and liquid samples | |
Chu | Evolutionary Genomics of Roseobacter in the Macroagal Ecosystem | |
EESHA | SYNTHESIZING, DIGITIZATION AND BIOPROSPECTING OF A MICROBIAL CULTURE COLLECTION CENTRE [KRISTU JAYANTI CULTURE COLLECTION CENTER] | |
Abdul-Rahman | Bacteriological Profile, Molecular Detection and Antimicrobial Susceptibility Test among Pre-term Babies in Erbil city, Iraq | |
Zavyalova et al. | Differential diagnosis of salmon fish yersiniosis by polymerase chain reaction | |
Softley | Advanced in vitro Oral Biofilm Modelling: Combining Culture Techniques with Next Generation Sequencing | |
Hasan et al. | Molecular Detection and Phylogenetic Analysis of Citrobacter Freundii Isolates From Broilers in AL-Diwaniyah Province of Iraq |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221101 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20221101 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221129 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230307 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230320 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230411 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230501 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7279983 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |